asa guidelines glp-1 New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review How should we approach patients

Dihexa exhibits blood-brain barrier penetration approximately 1000-fold more efficient than comparable peptide compounds, a remarkable property that fundamentally distinguishes it from most nootropic peptides

Retatrutide, because it adds glucagon receptor activation, may cause additional metabolic effects that neither semaglutide nor tirzepatide produce, including greater fat oxidation and potentially different hunger pattern changes

Why GLP-1 success in the real world looks different than in trials In the evolving landscape of GLP-1 trends, Ozempic (semaglutide) has garnered attention for its weight loss effects

Card Payment Pay securely using Visa, Mastercard, Google Pay, or Apple Pay

10.1172/JCI104147 23 Author Anonymous (1963)